Long-term results of the co-operative German-Austrian-Swiss osteosarcoma study group's protocol COSS-86 of intensive multidrug chemotherapy and surgery for osteosarcoma of the limbs
about
sameAs
Platinum-induced hearing loss after treatment for childhood cancerNeoadjuvant chemotherapy for high grade osteosarcoma of the extremities: long-term results for patients treated according to the Rizzoli IOR/OS-3b protocol.High dose ifosfamide in combination with high dose methotrexate, adriamycin and cisplatin in the neoadjuvant treatment of extremity osteosarcoma: preliminary results of an Italian Sarcoma Group/Scandinavian Sarcoma Group pilot study.Improvement in histologic response but not survival in osteosarcoma patients treated with intensified chemotherapy: a randomized phase III trial of the European Osteosarcoma Intergroup.Efficacy and safety of gemcitabine-docetaxel combination therapy for recurrent or refractory high-grade osteosarcoma in China: a retrospective study of 18 patients.Proximal tumor location and fluid-fluid levels on MRI predict resistance to chemotherapy in stage IIB osteosarcomaOsteosarcoma in pediatric patients and young adults: a single institution retrospective review of presentation, therapy, and outcomeWhat are the factors that affect survival and relapse after local recurrence of osteosarcoma?Strategies for the targeted delivery of therapeutics for osteosarcoma.Current treatment of osteosarcoma.Current treatment of high grade osteosarcoma of the extremity: review.Marginal resection for osteosarcoma with effective neoadjuvant chemotherapy: long-term outcomesResults of the Scandinavian Sarcoma Group XIV protocol for classical osteosarcoma: 63 patients with a minimum follow-up of 4 years.Long-term results (>25 years) of a randomized, prospective clinical trial evaluating chemotherapy in patients with high-grade, operable osteosarcoma.Prognostic value of tumor suppressors in osteosarcoma before and after neoadjuvant chemotherapy.Frontline treatment of localized osteosarcoma without methotrexate: results of the St. Jude Children's Research Hospital OS99 trialChemotherapy resistance in osteosarcoma: current challenges and future directions.Suboptimal chemotherapy is an adverse prognostic factor in osteosarcomaWhat can we learn from geographical comparisons of childhood cancer survival?Immune responses to the 105AD7 human anti-idiotypic vaccine after intensive chemotherapy, for osteosarcoma.Proton pump inhibitor chemosensitization in human osteosarcoma: from the bench to the patients' bedBiomarkers of Osteosarcoma, Chondrosarcoma, and Ewing Sarcoma.How can survival be improved in localized osteosarcoma?The adolescent and young adult with cancer: state of the art -- bone tumors.Chemotherapy for osteosarcoma - where does it come from? What is it? Where is it going?Review of management issues in relapsed osteosarcoma.The role of chemotherapy for metastatic, relapsed and refractory osteosarcoma.The indications and efficacy of conventional chemotherapy in primary and recurrent sarcoma.Developing a prognostic model for patients with localized osteosarcoma treated with uniform chemotherapy protocol without high dose methotrexate: A single-center experience of 237 patients.Metastatic osteosarcoma: a challenging multidisciplinary treatment.A meta-analysis of randomized control trials of surgical methods with osteosarcoma outcomes.Highly effective reduced toxicity dose-intensive pilot protocol for non-metastatic limb osteogenic sarcoma (SCOS 89).The Scandinavian Sarcoma Group: 30 years' experience.High-dose chemotherapy (HDC) and autologous hematopoietic stem cell transplantation (ASCT) as salvage therapy for relapsed osteosarcoma.Neoadjuvant chemotherapy for patients with synchronous multifocal osteosarcoma: results in eleven cases.Troglitazione affects survival of human osteosarcoma cells.Axial skeletal osteosarcoma: a 25-year monoinstitutional experience in children and adolescents.Osteosarcoma in very young children: experience of the Cooperative Osteosarcoma Study Group.Pulmonary metastases in children with osteosarcoma: characteristics and impact on patient survival.Neoadjuvant and adjuvant chemotherapy with high-dose ifosfamide, doxorubicin, cisplatin and high-dose methotrexate in non-metastatic osteosarcoma of the extremities: a phase II trial in Japan.
P2860
Q26470526-39EF67C6-8356-4195-AA10-79DEE8CE1C6EQ32100844-E26A7A7D-DC15-4754-B551-3C998403F590Q33342456-BC9C448B-337A-477E-AFE1-8E0CCB0829D8Q33373879-B3653162-3C4B-438E-B58A-CE836B87E664Q33400419-231A7221-DF08-41A8-A504-B7B2AA464C59Q33592170-DEBD1640-8DC0-48D6-B1B3-4E8C9BA05AB0Q33614621-71E25360-685C-4F65-AFE4-8C1B3D806AF1Q34161337-F46FFF2F-8164-43CE-87FE-68A0648C03BCQ34179495-FA1C8E2F-0826-4261-9A32-6EDF694CDED8Q34242261-4AA7E7D8-A622-4F13-B324-6D6E78A4AB69Q34307165-88757B0D-E68C-434A-842C-0F2F3B65B7BAQ34528144-1B912E72-7C85-4B42-A95B-A38188B10DB2Q34627906-556E6519-5B06-4B22-8C85-66A4D3CEE8F5Q34638659-F7259352-8718-4111-9E38-337E643ACC44Q35619493-66BD295C-D3E6-4E9B-A9E5-F2C2490D2002Q36503647-8ACE355D-E504-429D-B78D-C337DABFC538Q36532115-E3FDD0FA-C92C-4189-B86C-EFA8591CA6C3Q36535695-8BFDAB7D-2B94-4BF9-A2FB-5E7A448D3106Q36609560-15E4E209-26D1-4767-A265-CDB6E1F1F2A1Q36616704-4B592AFF-82C7-488B-87A5-F5A551209DB0Q37273398-7435F409-6FEC-4DA3-A62C-4F6512FF9C5BQ37740672-08005BA5-7EBE-46E8-B929-13579BE395BAQ37782098-B7245751-F1F6-4894-B8C2-B732DD2E51ACQ38108248-065724F1-6035-4BD7-991C-641A1A0E59C4Q38126943-7930402B-14F3-4675-A9A2-C1A5ECA11177Q38168922-C5ADADF8-2B05-44B0-8B67-9027FC9F3202Q38267782-9C8C5D5B-2BA3-4E83-ABBF-D9EA435039ACQ38315670-D526AAC4-D858-4FA4-997C-0517B8A3FDC0Q38588532-D7EE919E-100C-4CDE-916E-C62C8DD1BBEFQ38783252-555B03FF-0A57-4F23-83BD-544DFD2CAB3EQ39086751-DF859873-FFF2-4706-B3DB-DABA226AF5DDQ41002762-D8A95CA8-4C9B-4681-BF82-50E3E7C91DB4Q43589203-7FE814CD-D4D9-457C-8FE3-A6165E008A85Q43661037-8C0922F5-FFA4-4DAD-BBEE-ACCEC0E4A8DAQ43672088-152A0B0D-B2EE-4EE7-8BB9-A10901CE9D4FQ43938006-0E37E2FA-4F49-48D6-B017-A301FC8CA5FCQ43968973-0F48C640-8510-4B6E-8902-84EEB8B5AEA2Q45842022-A800579D-281B-45B0-82C9-38F00B8BD5ACQ46100492-23254C26-DBD2-4371-BD7F-5E0D181A102BQ46879986-4B30819A-B0AD-4E17-9CF3-24772B166A04
P2860
Long-term results of the co-operative German-Austrian-Swiss osteosarcoma study group's protocol COSS-86 of intensive multidrug chemotherapy and surgery for osteosarcoma of the limbs
description
article
@en
im August 1998 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в 1998
@uk
name
Long-term results of the co-op ...... for osteosarcoma of the limbs
@en
Long-term results of the co-op ...... for osteosarcoma of the limbs
@nl
type
label
Long-term results of the co-op ...... for osteosarcoma of the limbs
@en
Long-term results of the co-op ...... for osteosarcoma of the limbs
@nl
prefLabel
Long-term results of the co-op ...... for osteosarcoma of the limbs
@en
Long-term results of the co-op ...... for osteosarcoma of the limbs
@nl
P2093
P356
P1433
P1476
Long-term results of the co-op ...... for osteosarcoma of the limbs
@en
P2093
M Salzer-Kuntschik
P304
P356
10.1023/A:1008391103132
P50
P577
1998-08-01T00:00:00Z